CD44 and cancer: The addition of γ-secretase inhibitors, namely, MK-0752 [183] and RO4929097 [184], to chemo/radiotherapy gave indications of reducing cancer stem cell populations (CD44+, CD24−/low, ALDHhigh, and CD133+ cells), encouraging their assessment in haematological malignancies.